Last CNY13.84 CNY
Change Today -0.21 / -1.49%
Volume 8.4M
300039 On Other Exchanges
Symbol
Exchange
Shenzhen
As of 2:00 AM 12/19/14 All times are local (Market data is delayed by at least 15 minutes).

shanghai kaibao pharmaceut-a (300039) Snapshot

Open
CNY14.10
Previous Close
CNY14.05
Day High
CNY14.11
Day Low
CNY13.68
52 Week High
10/16/14 - CNY16.90
52 Week Low
05/29/14 - CNY11.63
Market Cap
8.9B
Average Volume 10 Days
9.6M
EPS TTM
CNY0.54
Shares Outstanding
640.4M
EX-Date
04/2/14
P/E TM
25.5x
Dividend
CNY0.22
Dividend Yield
1.57%
Current Stock Chart for SHANGHAI KAIBAO PHARMACEUT-A (300039)

Related News

No related news articles were found.

shanghai kaibao pharmaceut-a (300039) Related Businessweek News

No Related Businessweek News Found

shanghai kaibao pharmaceut-a (300039) Details

Shanghai Kaibao Pharmaceutical Co., Ltd. researches, develops, manufactures, and distributes Chinese medicines in China. The company offers clear away heat and toxic material injections, which are applied in the treatment of upper respiratory tract infections, such as cold and pneumonia; and doxofylline capsules for the treatment of bronchial asthma, chronic asthmatic bronchitis, and other breathing difficulties that are caused by bronchial spasms. It also provides pioglitazone hydrochloride tablets for the treatment of type 2 diabetes; captopril sustained-release tablets for treating high blood pressure and heart failure; and other drugs. Shanghai Kaibao Pharmaceutical Co., Ltd. was founded in 2000 and is based in Shanghai, China.

Founded in 2000

shanghai kaibao pharmaceut-a (300039) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

shanghai kaibao pharmaceut-a (300039) Key Developments

Shanghai Kaibao Pharmaceutical Co., Ltd. Announces Board Elections

Shanghai Kaibao Pharmaceutical Co., Ltd. announced that at the extraordinary general meeting held on 28 November 2014 approved the election of Mu Lai'an, Wang Guoming, Li Xiuhai, Xue Dongsheng and Mu Jingwei as directors and also approved the election of Feng Jianfang, Han Jing and Li Qingwei as independent directors.

Shanghai Kaibao Pharmaceutical Co., Ltd., Special/Extraordinary Shareholders Meeting, Nov 28, 2014

Shanghai Kaibao Pharmaceutical Co., Ltd., Special/Extraordinary Shareholders Meeting, Nov 28, 2014., at 13:30 China Standard Time. Agenda: To consider the election of non-independent directors; to consider the election of independent directors; and to consider the election of non-employee representative supervisors.

Shanghai Kaibao Pharmaceutical Co., Ltd. to Report Q3, 2014 Results on Oct 21, 2014

Shanghai Kaibao Pharmaceutical Co., Ltd. announced that they will report Q3, 2014 results on Oct 21, 2014

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
300039:CH CNY13.84 CNY -0.21

300039 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 300039.
View Industry Companies
 

Industry Analysis

300039

Industry Average

Valuation 300039 Industry Range
Price/Earnings 25.1x
Price/Sales 6.1x
Price/Book 4.9x
Price/Cash Flow 25.4x
TEV/Sales 5.5x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SHANGHAI KAIBAO PHARMACEUT-A, please visit www.xykb.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.